Key Highlights
- April deliveries from Tesla’s Shanghai facility reached 79,478 vehicles, up 36% versus last year
- Monthly deliveries declined 7.2% compared to March figures
- China’s Full Self-Driving regulatory approval timeline shifted to Q3 from initial Q1 projection
- Company insiders offloaded more than 80,000 shares totaling approximately $30.8 million recently
- Wall Street consensus stands at “Hold” with $398.42 mean price objective
The electric vehicle manufacturer reported a significant 36% annual increase in China-made vehicle deliveries for April, extending its positive year-over-year performance streak to half a year. Tesla’s Shanghai manufacturing hub shipped 79,478 electric vehicles during the month, servicing both domestic customers and international markets including Europe.
While this represents a 7.2% sequential decline from March’s 85,670-unit output, the annual comparison reveals continued growth momentum for the EV giant.
TSLA shares began Thursday trading at $398.75, posting approximately 2.4% gains. The equity trades within a 52-week bandwidth of $271.00 to $498.83, with the company commanding a $1.50 trillion market valuation.
Tesla has faced considerable headwinds in the Chinese market over the trailing twelve months. The manufacturer experienced a nearly 50% contraction in European market share during 2025, while aggressive pricing from domestic Chinese competitors intensified competitive pressures.
However, April’s delivery figures indicate potential market stabilization. The company also registered improved sales performance across multiple European territories last month, notably in Sweden, France, and Denmark.
Escalating petroleum prices connected to geopolitical tensions between the U.S. and Iran contributed to heightened battery electric vehicle demand throughout Europe.
Full Self-Driving Authorization Postponement Creates Uncertainty
A significant challenge affecting Tesla’s China expansion involves Full Self-Driving technology. Tesla currently anticipates obtaining complete FSD regulatory clearance in China during Q3, representing a delay from the initially projected Q1 timeframe.
Chief Financial Officer Vaibhav Taneja acknowledged this timeline extension during the company’s April quarterly earnings presentation. FSD authorization represents a critical competitive advantage in China, especially among affluent vehicle purchasers.
European regulatory authorities have similarly expressed reservations regarding the autonomous driving technology, based on correspondence examined by Reuters.
To maintain market competitiveness in China, Tesla is purportedly engineering a more affordable, compact sport utility vehicle for local manufacturing. This strategic initiative directly addresses the proliferation of budget-friendly Chinese electric vehicle models.
China’s overall new energy vehicle retail sales totaled 1.22 million units in April, representing 7% annual growth, according to data from the China Passenger Car Association.
BYD, Tesla’s principal Chinese competitor, experienced a 15% year-over-year sales contraction in April with 314,100 units delivered.
Executive Share Sales and Wall Street Outlook
Regarding financial performance, Tesla announced Q1 earnings per share of $0.41, surpassing analyst expectations of $0.39. Quarterly revenue reached $22.39 billion, marginally below the $22.96 billion consensus forecast.
Revenue demonstrated 15.8% year-over-year expansion. During Q1 2025, Tesla generated $0.27 EPS.
Company executives have been divesting holdings. Board member Kathleen Wilson-Thompson liquidated 26,409 shares on April 30 at an average transaction price of $378.11, generating nearly $10 million in proceeds. This transaction reduced her ownership position by 35.3%.
During the preceding 90-day period, corporate insiders collectively sold 80,213 shares valued at approximately $30.85 million.
Regarding institutional activity, Gateway Investment Advisers expanded its Tesla holdings by 0.5% during Q4, acquiring 2,279 additional shares to reach a total position of 498,845 shares worth approximately $224.3 million.
Wall Street analyst perspectives remain divided. Among 41 equity analysts tracking the stock, 19 maintain Buy ratings, 17 recommend Hold, and 5 advise Sell. The consensus price target stands at $398.42.
Truist Financial reduced its price objective from $438 to $400 while preserving a Hold recommendation on April 2. Bank of America maintains a Buy rating with a $460 price target.
